This week; the UK reached the grim milestone of 100,000 coronavirus deaths, new, more contagious UK, South Africa and Brazil virus variants are being linked to rising case numbers, and a row has surfaced between the UK and the EU over the speed of vaccine supply.
In brighter news, Novavax has just released UK trial results showing their vaccine to be almost 90% effective. This is good news for New Zealand, which has an agreement to buy 10.7 million doses in mid 2021.
Our regular commentator Cambridge University consultant clinical virologist Dr Chris Smith joins us with the latest Covid-19 science, and to answer your questions
